PhaseRx Inc. (NASDAQ:PZRX) Shares Jump 115% After FDA Grants Orphan Drug Designation for Ornithine Transcarbamylase Deficiency Treatment
All eyes are on shares of PhaseRx Inc. (NASDAQ:PZRX) this morning, after the FDA has given Orphan Drug Designation for one of the company’s most…